ArticleCancer research2025

Modeling Drug Responses and Evolutionary Dynamics Using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple-Negative Breast Cancer.

Abigail Shea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.